Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies

Human Vaccines

Volumn 3, Issue 5, 2007, Pages 192-195

  Muhamuda, Kader ^a   Madhusudana, Shampur Narayan ^a   Ravi, Vasanthapuram ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Hybridoma; Monoclonal antibodies; Passive immunization; Rabies; Rabies prophylaxis

Indexed keywords

IMMUNOGLOBULIN G2; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GUINEA PIG; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PROPHYLAXIS; RABIES; VIRUS STRAIN;

EID: 35348965131     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.5.4386     Document Type: Article

References (15)

1. Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NSN, Ashwath Narayana DH, Abdul Rahman S, Meslin F-X, Lobo D, Ravikumar K, Gangaboaraih. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 2007; 11:29-35.
2. Wilde H, Chomchey P, Prokongsri S, Puyaratabandhu P, Chutivongse S. Adverse effects of equine rabies immunoglobulin. Vaccine 1989; 7:10-1.
3. Gacouin A, Bourhy H, Renaud JC, Camus C, Suprin E, Thomas R. Human rabies despite postexposure vaccination. Eur J Clin Microbiol Infect Dis 1999; 18:233-5.
4. Hemachudha T, Mitrabhakdi E, Wilde H, Vejabhuri A, Siripataravanit S, Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 1999; 28:143-4.
5. World Health Organization. Expert consultation on rabies, WHO technical report series 931, first report. Geneva: WHO, 2005.
6. Wiktor TJ, Koprowski H. Monoclonal antibodies against rabies virus produced by somatic cell hybridization: Detection of antigenic variants. Proc Natl Acad Sci USA 1978; 75:3938-42.
7. Smith JS, Yager PA, Baer GM. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody. In: Meslin FX, Koprowsky H, Kaplan MM, eds. Laboratory techniques in rabies. 4th ed. Geneva: WHO, 1996:181-92.
8. Koprowski H. The mouse inoculation test. In: Meslin FX, Kaplan MM, Koprowski H, eds. Laboratory techniques in Rabies. 4th ed. Geneva: World Health Organization, 1996:80.
9. Fitzgerld EA. Potency test of antirabies serum and immunoglobulin. In: Meslin FX, Koprowsky H, Kaplan MM, eds. Laboratory techniques in rabies. 4th ed. Geneva: WHO, 1996:417-22.
10. Sears H, Herlyn D, STeplewski Z, Koprowski H. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinomal. J Biol Response Mod 1984; 3:138-50.
11. Sindlar WF, Maher MM, Herlyn D, Sears HF, Steplewski Z, Koprowski H. Triial of therapy of monoclonal antibody 17-1A in pancreatic carcinoma: Preliminary results. Hybridoma 1986; 5:S125-32.
12. Froedin JE, Biberfeld P, Christensson B, Philstedt P, Sundelius S, Sylven M, Wahren B, Koprowski H, Mellstedt H. Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies (Moab 17-1A): A progress report. Hybridoma 1986; 5:151.
13. Kimura-Kuroda J, Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 1988; 141:3606-10.
14. Jaijaroensup W, Tantawichien T, Khawplod P, Tepsumethanon S, Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 1999; 28:913-4.
15. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric antibody molecules: Mouse antigen binding domain with human constant region domain. Proc Natl Acad Sci USA 1984; 81:6851-56.